Stock Events

Stock Events

Mainz Biomed B.V. 

0
138
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14AugExpected
Q2 2025
Q2 2026
-2.26
-1.51
-0.77
-0.02
Expected EPS
-0.0172852
Actual EPS
N/A

Financials

-3,024.54%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
455,708.14Revenue
-13.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4TO.STU. It's not an investment recommendation.
NVIDIA
7
NVDA
Bitcoin
7
BTC.CRYPTO
Broadcom
7
AVGO
Microsoft
6
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health, Inc. provides liquid biopsy tests that detect cancer and cancer treatment targets, competing in the broader cancer diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics, Inc. provides comprehensive genetic testing solutions for various diseases, including cancer, competing in the genetic testing market.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen N.V. offers sample and assay technologies for molecular diagnostics, including cancer, competing in the molecular diagnostics market.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences of California, Inc. offers sequencing systems that could be used in cancer research and diagnostics, indirectly competing in the genomics space.
Illumina
ILMN
Mkt Cap32.55B
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis, which are crucial in cancer research and diagnostics, making it a competitor in the genomics field.
TG Therapeutics
TGTX
Mkt Cap8.26B
TG Therapeutics, Inc. focuses on developing treatments for B-cell malignancies and autoimmune diseases, competing in the broader oncology and biopharmaceutical market.
Adaptive Biotechnologies
ADPT
Mkt Cap4.02B
Adaptive Biotechnologies Corp. offers clonoSEQ, a diagnostic test for detecting minimal residual disease in blood cancers, competing in the cancer diagnostics and monitoring market.

About

Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
Show more...
CEO
David Elliot Lazar
Employees
13
Country
Netherlands
ISIN
NL0015000LC2
WKN
000A3C6XX

Listings

MU
DE
4TO.MU
STU
DE
4TO.STU
XNAS
US
QUCY
BOATS
BOATS
MYNZ.BOATS

0 Comments

Share your thoughts

FAQ

What is Mainz Biomed B.V. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Mainz Biomed B.V. stocks are traded under the ticker 4TO.STU.
When is the next Mainz Biomed B.V. earnings date?▼
Mainz Biomed B.V. is going to release the next earnings report on March 03, 2027.
What is Mainz Biomed B.V. revenue for the last year?▼
Mainz Biomed B.V. revenue for the last year amounts to 455,708.14 EUR.
What is Mainz Biomed B.V. net income for the last year?▼
4TO.STU net income for the last year is -13.78M EUR.
How many employees does Mainz Biomed B.V. have?▼
As of September 04, 2026, the company has 13 employees.
In which sector is Mainz Biomed B.V. located?▼
Mainz Biomed B.V. operates in the Health & Wellness sector.
When did Mainz Biomed B.V. complete a stock split?▼
The last stock split for Mainz Biomed B.V. was on December 03, 2024 with a ratio of 1:40.
Where is Mainz Biomed B.V. headquartered?▼
Mainz Biomed B.V. is headquartered in MAINZ, Netherlands.